Paul Mercer

Paul has experience working both in the pharma setting and academia through positions at Pfizer, Novartis and Imperial College London before joining the group of Professor Rachel Chambers at UCL. His latest position was a Principal Research Associate at UCL.

Paul has a successful track record of leading collaborative research involving pharma and academia, translating basic research into novel therapeutics for difficult-to-treat chronic respiratory diseases. These projects have ranged from target discovery through to clinical proof of concept.

He managed a ground-breaking experimental medicine consortium - EMINENT (Experimental Medicine Initiative to Explore New Therapies) - supported by the MRC and GSK, and involving research groups from five leading UK academic institutions.